Pharmacy Trial Program

This page provides information about the Pharmacy Trial Program.

Page last updated: 06 April 2017

Latest News

Approach to Market

The PTP tranche 2 Approach to Market applications closed on 15 December 2016. Applications have now closed and the assessment process has commenced.

Trials Advisory Group (TAG)
Principles for the Pharmacy Trial Program
Tranche 1 of the PTP
Tranche 2 of the PTP
Stakeholder Engagement
Key Activities and Dates
Contacts and relevant links


The Australian Government recognises the important role that community pharmacists and pharmacies play in our health system and is committed to supporting pharmacies across Australia in providing access to Pharmaceutical Benefits Scheme (PBS) medicines and effective health care services.

The Pharmaceutical Benefits Scheme Access and Sustainability Package is a group of measures which will deliver funding for community pharmacy through the Sixth Community Pharmacy Agreement (Sixth Agreement).

The total funding allocated for community pharmacy programs is $1.26 billion over five years, (2015-16 to 2019-20). This includes:
  • $613 million to support community pharmacy programs that are continuing from the Fifth Community Pharmacy Agreement and which are assessed as clinically and cost effective;
  • $50 million to support a new Pharmacy Trial Program (PTP). This program will fund a number of trials to improve patient outcomes, and seeks to expand the role of pharmacy in delivering a wider range of primary healthcare services; and
  • $600 million to support a range of new and/or expanded programs, based on the recommendations of an independent health technology assessment body such as the Medical Services Advisory Committee about the outcomes of trials.
It is intended that a particular focus of the new, continuing and expanded Community Pharmacy Programs will be those which benefit:
    (a) Aboriginal and Torres Strait Islander peoples; and
    (b) consumers in rural and remote areas.

Trials Advisory Group (TAG)

The TAG has been established as an independent expert advisory committee to provide advice to the Department on the development and implementation of trials under the PTP.
More information is available on the Trials Advisory Group page.

Principles for the Pharmacy Trial Program

Please find attached Principles (PDF 23 KB) - Principles (Word 23 KB), which will underpin the PTP and trials that are funded.

Tranche 1 of the PTP

Tranche 1 of the PTP involves topics identified from previous research and development work undertaken under previous community pharmacy agreements or through discussions and negotiations on the PBS Access and Sustainability Measure.

On 17 March 2016 at the Australian Pharmacy Professional Conference, the Minister for Health and Aged Care, announced the three trial topics for the first tranche of the PTP. These trials will be led by the Pharmacy Guild of Australia and its partners in the following areas:
  • improved medication management for Aboriginal and Torres Strait Islanders through pharmacist advice and culturally appropriate services;
  • pharmacy based screening and referral for diabetes; and
  • improved continuity in the management of patients’ medications when they are discharged from hospital.
The TAG is providing advice on the development of the tranche 1 trials.

Grant Guidelines for Tranche 1 of the PTP

Word version of the Grant Guidelines for Tranche 1 of the PTP (Word 84 KB)
PDF version of the Grant Guidelines for Tranche 1 of the PTP (PDF 277 KB)

Tranche 2 of the PTP

The PTP tranche 2 Approach to Market was released on 25 October 2016 and closed 15 December 2016. The assessment process has now commenced.

Grant Guidelines for Tranche 2 of the PTP can be accessed via Grant Connect.

Stakeholder Engagement

Stakeholder involvement, input and support from the consumer, pharmacy, pharmaceutical and medical sectors will be essential in assisting the Department in designing and implementing the PTP, and determining trial priorities.

The consultation process for the PTP commenced with a public forum on 26 October 2015, which a number of national peak groups and stakeholders attended. Please see the Forum Report (PDF 68 KB) - Forum Report (Word 33 KB).

The Department released a Discussion Paper (PDF 230 KB) - Discussion Paper (Word 362 KB), between 17 March 2016 and 29 April 2016 with a high level ‘Call for Ideas’ from stakeholders. The Department received 108 responses to the consultation process. The information collected through the consultation process was used to develop priority themes for the PTP for consideration by the Minister for Health and Aged Care. Once themes for the PTP have been developed, second and further tranches will include formal calls for submissions.

Over the coming months, the Department will continue to consult with a range of stakeholders and bodies as required.

This page will be updated, and identified stakeholders notified, when further information is available. If you have not already noted your interest to the Department and wish to be emailed regarding updates, you can register your interest by clicking on the subscribe button below and entering your name and email address.

Key Activities and Dates

The key activities for the PTP in 2017 include:
  • Assessment process of applications for tranche 2 of the PTP – April/May 2017
  • Notifications to successful applicants resulting from the tranche 2 competitive funding process – May 2017
Key activities for 2015-16 included:
  • TAG meeting on 30 November 2016– Rescheduled date to be advised
  • TAG meeting on 20 September 2016
  • TAG meeting on 24 August 2016 – Rescheduled
  • Release of a discussion paper with a ‘Call for Ideas’ in March 2016
  • TAG meeting on 15 March 2016
  • Bilateral meetings with key stakeholders commencing in February 2016 and ongoing
  • First TAG meeting held on 22 January 2016
  • Establishment of the Trials Advisory Group (TAG)
  • Stakeholder consultation forum held 26 October 2015

Contact Us

If you wish to contact the Department in relation to the PTP, you can do so via the Pharmacy Trial Programme email address: (

Relevant Links